Results 211 to 220 of about 23,670 (299)

A practical starting guide to tear fluid biobanking. [PDF]

Adv Ophthalmol Pract Res
Schmeetz J, Hagan S, van de Sande N, Boychev N, Kessal K, Tear Research Network Biobanking Taskforce, Gijs M.   +6 more
europepmc   +1 more source

Altered gene expression in the liver and small intestine of horses with equine neuroaxonal dystrophy

Equine Veterinary Journal, EarlyView.
Abstract Background Equine neuroaxonal dystrophy/degenerative myeloencephalopathy (eNAD/EDM) is the second most common diagnosis of spinal ataxia in horses in the United States. The disease develops due to a combination of vitamin E deficiency and an unknown genetic risk factor(s), and there currently is no effective treatment.
Stephanie Ryan, Blythe Durbin‐Johnson, Kevin Woolard, Andrew D. Miller, Carrie J. Finno   +4 more
wiley   +1 more source

When genomics companies act as biobanks: governance challenges in an era of genomic assetization. [PDF]

Front Genet
Walker A.
europepmc   +1 more source

Multi‐Cohort Analysis Reveals Genetic Predispositions to Clonal Hematopoiesis as Mutation‐Specific Risk Factors for Stroke

Advanced Genetics, Volume 6, Issue 1, March 2025.
This study comprehensively evaluated the differential effect of clonal hematopoiesis (CH) mutations on the risk of various stroke subtypes and functional recovery. It shows that TET2 is associated with small vessel stroke possibly via a pro‐inflammatory pathway. Abstract Recent observational studies have found an association between Clonal Hematopoesis
Shuyang Lin, Yang E. Li, Yan Wang
wiley   +1 more source

Phenome- and laboratory-wide meta-analyses of sickle cell trait reveal multi-system disease associations. [PDF]

Am J Hum Genet
Hysong MR, Shuey MM, Miller-Fleming TW, Keat K, Stilp AM, Li Y, Cox NJ, Auer PL, Franceschini N, Verma A, Raffield LM, Reiner AP.   +11 more
europepmc   +1 more source

Beyond Conventional PDOs: Organoids for Tumorigenesis for Gut Cancer Modeling and Fast Clinical Decision

Gut Medicine, EarlyView.
ABSTRACT Reproducing tumor biology in vivo using three‐dimensional organoids remains a debated topic in the cancer organoid field, despite the new FDA framework for evaluating cancer drugs with organoid models. Compared with patient‐derived organoids (PDOs), which offer a humanized model for testing cancer therapies, organoids derived from normal stem ...
Chong Gao
wiley   +1 more source

Organoids: Current Applications and Future Directions. [PDF]

MedComm (2020)
Leng Y, Wang Y, Cao C, Deng F, Lian W, Chen X, Lin M, Zeng Z, Mo D, Li S, He Y, Yu Y, Pan H, Zhou P, Li R.   +14 more
europepmc   +1 more source

Human Biobanks

, 1997
Nordic Committee on Bioethics
core  

Informed consent and biobanks

, 2005
Clayton, Ellen Wright
core  

Centralised Identification of Early-Gestation Biospecimens to Support Early-Onset Pre-Eclampsia Prediction. [PDF]

BJOG
Philip CE, Faysal H, Quinney SK, Feng S, Haas DM.   +4 more
europepmc   +1 more source